The best indicator for West Pharmaceutical Services (WST)
We backtested 366 indicators across daily, weekly and hourly charts on real West Pharmaceutical Services (WST) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Guppy Multiple MA
On the daily chart, this is the strongest risk-adjusted edge we found for West Pharmaceutical Services (WST) over ~46.2 years — trailing buy-and-hold by 2.4% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for West Pharmaceutical Services (WST) — trailing buy-and-hold by 5.2% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Guppy Multiple MA ✓ | Daily | 12.9% | 0.68 | -41.4% | 41.5% | 159 | -2.4% |
| 2 | KAMA 200 Trend ✓ | Daily | 12.5% | 0.68 | -42.9% | 39.8% | 221 | -2.8% |
| 3 | RSI (25) ✓ | Daily | 12.8% | 0.68 | -42.6% | 38.9% | 388 | -2.5% |
| 4 | Disparity (50) ✓ | Daily | 12.9% | 0.68 | -41.5% | 39.0% | 387 | -2.4% |
| 5 | EMA 100 Trend ✓ | Daily | 12.6% | 0.67 | -45.5% | 39.1% | 230 | -2.7% |
| 6 | EMA 10/40 Cross ✓ | Daily | 12.8% | 0.67 | -42.2% | 44.1% | 143 | -2.6% |
| 7 | RSI (30) ✓ | Daily | 12.6% | 0.67 | -44.6% | 39.3% | 349 | -2.7% |
| 8 | RSI (50) ✓ | Daily | 12.5% | 0.67 | -44.2% | 39.3% | 229 | -2.8% |
| 9 | Disparity (100) ✓ | Daily | 12.6% | 0.67 | -45.5% | 39.1% | 230 | -2.7% |
| 10 | Price Volume Trend ✓ | Weekly | 13.2% | 0.67 | -42.1% | 55.3% | 76 | -2.1% |
| 11 | G-Channel ✓ | Daily | 12.6% | 0.67 | -48.1% | 40.3% | 268 | -2.7% |
| 12 | WMA 100 Trend ✓ | Daily | 11.9% | 0.66 | -44.2% | 40.4% | 272 | -3.4% |
| 13 | DEMA 200 Trend ✓ | Daily | 10.7% | 0.65 | -44.2% | 40.6% | 251 | -4.7% |
| 14 | McGinley 30 Trend ✓ | Daily | 12.7% | 0.65 | -45.0% | 36.2% | 307 | -2.6% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For West Pharmaceutical Services (WST), Guppy Multiple MA on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.